biotech · Relapsed or Refractory B-cell Malignancies · Solid Tumor · RXRX
RECURSION PHARMACEUTICALS
RECURSION PHARMACEUTICALS, INC.
RECURSION PHARMACEUTICALS patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Staten Island, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 2
- Patents
- 4
RECURSION PHARMACEUTICALS patents
4 pharmaceutical patents indexed for RECURSION PHARMACEUTICALS. 0 expire within 24 months.
RECURSION PHARMACEUTICALS has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11919868
Heterocyclic compounds and related methods
granted -
US 11033494
Apparatuses containing an emulsion and methods of manufacture
granted -
US 6331564
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
expired -
US 6028103
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
expired
Frequently asked questions
How many patents does RECURSION PHARMACEUTICALS have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do RECURSION PHARMACEUTICALS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.